Search results
Results from the Tech24 Deals Content Network
August 8, 2024 at 11:52 AM. Shares of Viatris (NASDAQ: VTRS) were jumping 6% higher as of 11:18 a.m. ET on Thursday after rising as much as 12.4% earlier in the day. The solid gain came after the ...
Should you invest $1,000 in Viatris right now? ... analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viatris wasn’t one of them. The 10 stocks ...
Viatris (VTRS) closed the most recent trading day at $15.17, moving -0.98% from the previous trading session.
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
Falling by about 23% right after the news, and down around 32.5% in the past month, it may take some time for Viatris to bounce back. ... was considered a value play among drug stocks. But after ...
You should check […] Mittleman Investment Management’s composite gained 25.9% net of fees in the first quarter of 2021, versus gains of 6.2% in the S&P 500 Total Return Index and 12.7% in the ...
Viatris was formed with the merger of Mylan and Pfizer's Upjohn business and has generic and key branded drugs in its portfolio, including erectile dysfunction drug Viagra, anti-anxiety medication ...
Viatris (VTRS) closed the most recent trading day at $10.99, moving -1.7% from the previous trading session. Viatris (VTRS) Dips More Than Broader Markets: What You Should Know Skip to main content